BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Floods, Landslides Triggered By Heavy Rain In Afghanistan Leave 77 Dead In 10 days, Authorities Say - 2World’s tallest bridge and biggest museum named ‘greatest places of 2026’
- 3Alice Wong, founder of the Disability Visibility Project, dies at 51
- 4UN chief warns he could refer Israel to ICJ over laws targetting UNRWA
- 5Hot peppers sent him to the ER. Two years later, a ‘ghost bill’ arrived.
- Newly identified species of Tanzanian tree toad leapfrog the tadpole stage and give birth to toadlets
- The Forgotten BMW Coupe That Turned a 5 Series Into Something Far More Exotic
- Story of ‘first Black Briton’ rewritten by advances in ancient DNA technology
- Figure out How to Advance Space in Your Pre-assembled Home for Upgraded Usefulness
- Figure out How to Pick the Right Dental specialist for Your Dental Inserts
- The most effective method to Augment Benefits in Gold Speculation: Systems and Tips
- Popular Film Areas: A Worldwide Manual for Film Enchantment
- Recent studies prove the ancient practice of nasal irrigation is effective at fighting the common cold
- Why ordering takeout or calling the dog walker might lead to a happier relationship
